These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 27622332)

  • 1. Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses.
    Young A; Ngiow SF; Barkauskas DS; Sult E; Hay C; Blake SJ; Huang Q; Liu J; Takeda K; Teng MWL; Sachsenmeier K; Smyth MJ
    Cancer Cell; 2016 Sep; 30(3):391-403. PubMed ID: 27622332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD73-adenosine: a next-generation target in immuno-oncology.
    Allard D; Allard B; Gaudreau PO; Chrobak P; Stagg J
    Immunotherapy; 2016 Feb; 8(2):145-63. PubMed ID: 26808918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors.
    Beavis PA; Divisekera U; Paget C; Chow MT; John LB; Devaud C; Dwyer K; Stagg J; Smyth MJ; Darcy PK
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14711-6. PubMed ID: 23964122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis.
    Stagg J; Divisekera U; Duret H; Sparwasser T; Teng MW; Darcy PK; Smyth MJ
    Cancer Res; 2011 Apr; 71(8):2892-900. PubMed ID: 21292811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs.
    Allard B; Pommey S; Smyth MJ; Stagg J
    Clin Cancer Res; 2013 Oct; 19(20):5626-35. PubMed ID: 23983257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purinergic targeting enhances immunotherapy of CD73
    Wang J; Lupo KB; Chambers AM; Matosevic S
    J Immunother Cancer; 2018 Dec; 6(1):136. PubMed ID: 30514403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular purine metabolism and signaling of CD73-derived adenosine in murine Treg and Teff cells.
    Romio M; Reinbeck B; Bongardt S; Hüls S; Burghoff S; Schrader J
    Am J Physiol Cell Physiol; 2011 Aug; 301(2):C530-9. PubMed ID: 21593451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased efficacy of a dendritic cell-based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor.
    Arab S; Kheshtchin N; Ajami M; Ashurpoor M; Safvati A; Namdar A; Mirzaei R; Mousavi Niri N; Jadidi-Niaragh F; Ghahremani MH; Hadjati J
    Tumour Biol; 2017 Mar; 39(3):1010428317695021. PubMed ID: 28349824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice.
    Wang L; Fan J; Thompson LF; Zhang Y; Shin T; Curiel TJ; Zhang B
    J Clin Invest; 2011 Jun; 121(6):2371-82. PubMed ID: 21537079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygenation and A2AR blockade to eliminate hypoxia/HIF-1α-adenosinergic immunosuppressive axis and improve cancer immunotherapy.
    Halpin-Veszeleiova K; Hatfield SM
    Curr Opin Pharmacol; 2020 Aug; 53():84-90. PubMed ID: 32841869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD73 on T Cells Orchestrates Cardiac Wound Healing After Myocardial Infarction by Purinergic Metabolic Reprogramming.
    Borg N; Alter C; Görldt N; Jacoby C; Ding Z; Steckel B; Quast C; Bönner F; Friebe D; Temme S; Flögel U; Schrader J
    Circulation; 2017 Jul; 136(3):297-313. PubMed ID: 28432149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models.
    Leone RD; Sun IM; Oh MH; Sun IH; Wen J; Englert J; Powell JD
    Cancer Immunol Immunother; 2018 Aug; 67(8):1271-1284. PubMed ID: 29923026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD73: a novel target for cancer immunotherapy.
    Zhang B
    Cancer Res; 2010 Aug; 70(16):6407-11. PubMed ID: 20682793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.
    Jin D; Fan J; Wang L; Thompson LF; Liu A; Daniel BJ; Shin T; Curiel TJ; Zhang B
    Cancer Res; 2010 Mar; 70(6):2245-55. PubMed ID: 20179192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered purinergic signaling in CD73-deficient mice inhibits tumor progression.
    Yegutkin GG; Marttila-Ichihara F; Karikoski M; Niemelä J; Laurila JP; Elima K; Jalkanen S; Salmi M
    Eur J Immunol; 2011 May; 41(5):1231-41. PubMed ID: 21469131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of the adenosine receptor and CD73 in the regulatory effect of γδ T cells.
    Liang D; Zuo A; Shao H; Chen M; Kaplan HJ; Sun D
    PLoS One; 2014; 9(9):e108932. PubMed ID: 25268760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecto-5'-nucleotidase (CD73)-mediated formation of adenosine is critical for the striatal adenosine A2A receptor functions.
    Augusto E; Matos M; Sévigny J; El-Tayeb A; Bynoe MS; Müller CE; Cunha RA; Chen JF
    J Neurosci; 2013 Jul; 33(28):11390-9. PubMed ID: 23843511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD73 expression on effector T cells sustained by TGF-β facilitates tumor resistance to anti-4-1BB/CD137 therapy.
    Chen S; Fan J; Zhang M; Qin L; Dominguez D; Long A; Wang G; Ma R; Li H; Zhang Y; Fang D; Sosman J; Zhang B
    Nat Commun; 2019 Jan; 10(1):150. PubMed ID: 30635578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecto-5'-nucleotidase (CD73) attenuates allograft airway rejection through adenosine 2A receptor stimulation.
    Ohtsuka T; Changelian PS; Bouïs D; Noon K; Harada H; Lama VN; Pinsky DJ
    J Immunol; 2010 Jul; 185(2):1321-9. PubMed ID: 20548026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement of NK cells for selective A2A receptor blockade to suppress CD73+ tumor metastasis.
    Qin L; Thompson LF; Kuzel TM; Zhang B
    Immunotherapy; 2014; 6(1):19-21. PubMed ID: 24341879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.